Statistics for Gilead Sciences (id:7062 GILD)
Valuation metrics
Market cap
110.46B
Enterprise value
125.83B
Trailing P/E (ttm)
984.78
Forward P/E
11.93
PEG ratio
11.93
Price/Sales (ttm)
3.90
Price/Book (mrq)
5.98
Enterprise Value/Revenue
4.45
Enterprise Value/EBITDA
9.02
Overview
Shares outstanding
1.25B
Float
1.24B
Shares short
17.74M
% Held by insiders
0.00%
% Held by institutions
0.88%
Average volume (10 days)
8.96M
Average volume (90 days)
Price summary
52-Week low
62.07
52-Week high
98.90
52-Week change
14.95%
Beta
0.19
50-Day moving average
86.99
200-Day moving average
74.95
Dividends and splits
Forward annual dividend rate
3.08
Forward annual dividend yield
0.03
Trailing annual dividend rate
3.06%
Trailing annual dividend yield
0.03
5-Year annual dividend yield
4.02
Payout ratio
34.00
Dividend date
December 30th, 2024
Ex-dividend date
December 13th, 2024
Last split factor
2:1
Last split date
January 28th, 2013
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.44%
Operating margin
41.96%
Operational effectiveness
Return on assets
11.96%
Return on equity
0.56%
Income statement
Revenue (ttm)
22.70
Revenue per share (ttm)
22.70
Quarterly revenue growth (yoy)
-0.42
Gross profit (ttm)
20.62B
EBITDA
10.48B
Net income to common (ttm)
126.00M
Diluted EPS (ttm)
0.09
Quarterly earnings growth (yoy)
-42.50%
Balance sheet
Total cash (mrq)
6.70B
Total cash per share (mrq)
5.37
Total debt (mrq)
23.25B
Total Debt/Equity (mrq)
126.42
Current ratio (mrq)
126.00%
Book value per share (mrq)
14.83
Cash flow
Cash flow statement
10.02B
Levered free cash flow (LFCF)
9.08B